» Articles » PMID: 17393984

The Expression of Hepatocyte Nuclear Factor-4alpha, a Developmental Regulator of Visceral Endoderm, Correlates with the Intestinal Phenotype of Gastric Adenocarcinomas

Overview
Journal Pathology
Specialty Pathology
Date 2007 Mar 31
PMID 17393984
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Hepatocyte nuclear factor (HNF)-4alpha is a developmental regulator of the visceral endoderm, which is expressed in the embryonic gut and later in the adult intestine and colon. However, adult gastric mucosa does not express HNF-4alpha. We investigated the possible involvement of HNF-4alpha in intestinal metaplasia and the intestinalisation of gastric adenocarcinomas.

Methods: Thirty-five cases of adenocarcinomas and 46 cases of adjacent non-neoplastic mucosa with (22 lesions) or without (24 lesions) intestinal metaplasia were immunostained for HNF-4alpha. The gastric or the intestinal phenotype was also examined using immunohistochemistry for MUC5AC, MUC2, CD10, and gastric-type mucin (GTM). Adenocarcinomas were classified into the gastric type (G-type, 42.9%), the mixed gastric and intestinal type (GI-type, 31.4%), and the intestinal type (I-type, 25.7%).

Results: The HNF-4alpha expression was exclusively seen in glandular cells with intestinal metaplasia, which was correlated with MUC2 expression (p<0.05) and inversely correlated with MUC5AC expression (p<0.05). All adenocarcinomas more or less expressed HNF-4alpha, with an intense expression being seen in the I-type (p<0.01) and in well-differentiated adenocarcinomas (p<0.03).

Conclusions: HNF-4alpha expression is associated with the intestinal phenotype of non-neoplastic and neoplastic gastric glandular cells, suggesting a possible involvement in the establishment and/or maintenance of the intestinal phenotype of the gastric mucosa and adenocarcinomas.

Citing Articles

Gastric Adenocarcinomas with CDX2 Induction Show Higher Frequency of and Mutations and Amplifications but Similar Survival Compared with Cancers with No CDX2 Induction.

Voutsadakis I J Clin Med. 2025; 13(24.

PMID: 39768557 PMC: 11727917. DOI: 10.3390/jcm13247635.


Exploration of gastric carcinogenesis from the relationship between bile acids and intestinal metaplasia and intragastric microorganisms (H. pylori and non-H. pylori).

Lei X, Cui Z, Huang X J Cancer Res Clin Oncol. 2023; 149(18):16947-16956.

PMID: 37707577 DOI: 10.1007/s00432-023-05407-5.


Berberine retarded the growth of gastric cancer xenograft tumors by targeting hepatocyte nuclear factor 4α.

Li L, Peng Z, Hu Q, Xu L, Zou X, Huang D World J Gastrointest Oncol. 2022; 14(4):842-857.

PMID: 35582103 PMC: 9048536. DOI: 10.4251/wjgo.v14.i4.842.


Transcription factor-mediated intestinal metaplasia and the role of a shadow enhancer.

Singh H, Seruggia D, Madha S, Saxena M, Nagaraja A, Wu Z Genes Dev. 2021; 36(1-2):38-52.

PMID: 34969824 PMC: 8763054. DOI: 10.1101/gad.348983.121.


Disruption of Tumor Suppressors HNF4α/HNF1α Causes Tumorigenesis in Liver.

Teeli A, Luczynska K, Haque E, Gayas M, Winiarczyk D, Taniguchi H Cancers (Basel). 2021; 13(21).

PMID: 34771521 PMC: 8582545. DOI: 10.3390/cancers13215357.